Princeton develops bionic ear; Israel developing as med tech hotbed;

 @FierceMedDev: Boston Scientific's Watchman AF device generates more stunning data. Story | Follow @FierceMedDev

 @MarkHFierce: Swiss stent maker Bioensors Int'l will pay $51M for a U.S. imaging company - diversification program now under way. More | Follow @MarkHFierce

 @DamianFierce: Glaxo is reaching into Hong Kong with a new DKSH partnership, targeting antibiotics. Article | Follow @DamianFierce

> Princeton University researchers have come up with a bionic ear, made from a 3-D printer, with a radio antenna woven into the cartilage. Story

> Austria's MED-EL Medical Electronics says a Toronto patient can now hear music and voices thanks to the successful implantation of its Bonebridge bone conduction hearing implant. Release

> Tyrx, a 2012 Fierce 15 winner, is celebrating new study results showing its AigisRx antibacterial envelope slashed major infection rates by more than 90% in patients undergoing cardiovascular device (pacemaker or ICD) implant replacement procedures. Release

> Welch Allyn has launched its next-generation Connex vital signs monitor in Canada, touting the device as providing more accurate diagnoses than competing products. More

> Self-expanding stents can greatly improve outcomes for patients with heart disease, The Times of India reports. Story

> Israel's medical device industry is still relatively new, but its potential is beginning to mushroom. Item

Biotech News

 @FierceBiotech:  FDA accepts $BIIB's BLA for 1st long-lasting factor VIII therapy for hemophilia A. Release | Follow @FierceBiotech

 @JohnCFierce: J&J gets a priority review for hep C drug simeprevir (with Medivir). More | Follow @JohnCFierce

 @RyanMFierce:  Mobile service PharmaSecure finds demand in losing fight against fake drugs. Story | Follow @RyanMFierce

> Vectura joins forces with a new JV biotech in China for respiratory therapies. News

> Class action suits pile up at Aveo's doorstep in wake of FDA debacle. More

> Elan pays $1B for a slice of Theravance's COPD franchise royalty stream. News

Pharma News

 @FiercePharma: FDA nixes Endo petition to protect Opana ER from generics. Article | Follow @FiercePharma

> AbbVie research chief heads for the exits, amid rash of top R&D departures. Story

> Actavis, Warner Chilcott in buyout talks worth $5B-plus. Article

> GlaxoSmithKline's Breo nod augurs new respiratory franchise, analysts say. More

CRO News

> Argentine CRO Stat Research taps Datatrak. News

> Harlan Labs doubles in specialty research with U.S. expansion. Story

> PRA boosts informatics with Welsh expansion. More

> Quintiles hauls in $947M IPO after upping offering. Report

> AMRI piles on profits with strong Q2. Article

Biotech IT News

> Pfizer tests online Viagra sales to beat the cheats. News

> IT outfit Instem acquires Logos to penetrate early clinical trials market. More

> GlaxoSmithKline exec details expectations for online clinical trial research. Article

> Hong Kong billionaire backs Big Data effort in biomedicine at Oxford University. Story

> Pfizer opts to keep running Accelrys software in its labs. Article